139) een unaddressed because of the absence of high quality evidence. |
140) We identified 4,296 high quality homozygous SNPs and indels be |
141) udies were categorized having moderate-to-high quality. |
142) toxicities while recurrence rates remain high. |
143) MA efficacy rankings based on PASI 75 was high. |
144) The implementation quality was high. |
145) hile ARG abundance and diversity remained high. |
146) hods evaluated in the studies were strong/high. |
147) cellular delivery of biologics, combining high efficiency and throughput with excell |
148) ly, the modified polymer adsorbent with a high efficiency for cobalt ions adsorption |
149) r advantages, such as low operating cost, high efficiency. |
150) subtype-specific vulnerability genes with high efficiency. |
151) able of producing 8-prenylkaempferol with high efficiency. |
152) omen from geographic areas of the US with high rates of cervical cancer to adapt int |
153) There are high rates of distress, mental disorder, p |
154) persons experiencing homelessness achieve high rates of linkage to care in non-speci |
155) re does not currently exist, resulting in high rates of mortality and morbidity. |
156) lence during migration and typically have high rates of post-traumatic stress disord |
157) o health, and patients often rate it as a high-priority clinical outcome. |
158) More high-quality clinical studies are needed t |
159) 1, 2020, and May 15, 2020, we identified high-quality clinical studies describing c |
160) There is therefore a clear need for new, high-quality clinical studies of this topi |
161) High concentrations up to 108 ng/L were f |
162) ng autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma d |
163) al population, that auto-Abs neutralizing high concentrations of IFN-α and/or -ω a |
164) eased patients have auto-Abs neutralizing high concentrations of IFN-β. |
165) at both individual and household level in high-income countries, and with respondent |
166) eligible articles, mainly originated from high-income countries, describing the deve |
167) have mainly drawn on studies published in high-income countries, including very few |
168) Most of the studies were from the high-income countries, reflecting the need |
169) vestigating the cardiovascular effects of high-dose exercise have excluded or under- |
170) emales in studies assessing the impact of high-dose exercise on cardiovascular outco |
171) for studies that assessed the effects of high-dose exercise on cardiovascular outco |
add keyword